Alpha Tau Medical
NASDAQ: DRTSIncorporated in Israel · 2 known investors
Alpha TAU Medical is a clinical-stage oncology company developing Alpha DaRT, an intratumoral alpha-emitting radiotherapeutic that places radium-224 sources inside solid tumors to destroy cancer cells from within. Its tumor-agnostic approach targets multiple solid tumor types, including superficial and deep-seated, metastatic, and inoperable tumors, and is being evaluated as a stand-alone therapy and in combination with systemic agents.
BiotechHealthtechMedical Devices
Investors · 2
Competitors · 2
by search overlap
Vedantu14 shared keywordsVedantu is an online learning platform that provides free chapter-wise NCERT solutions and study materials for Class 12 CBSE students across Science, Commerce, and Arts subjects. It also offers resources for competitive exam preparation such as JEE and NEET, aligned with the latest CBSE syllabus.
Onco Invent11 shared keywordsOncoinvent develops alpha-particle radiotherapy for cancer treatment, with a lead product candidate, Radspherin, that uses inorganic microparticles carrying alpha-emitting radionuclides to treat cancer in the peritoneal cavity. The company operates in the biotech and radiopharmaceutical space.
Companies competing with Alpha Tau Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Alpha Tau Medical do?
- Alpha TAU Medical is a clinical-stage oncology company developing Alpha DaRT, an intratumoral alpha-emitting radiotherapeutic that places radium-224 sources inside solid tumors to destroy cancer cells from within. Its tumor-agnostic approach targets multiple solid tumor types, including superficial and deep-seated, metastatic, and inoperable tumors, and is being evaluated as a stand-alone therapy and in combination with systemic agents.
- Who are Alpha Tau Medical's investors?
- Alpha Tau Medical's investors include Das & Co., Deep Insight.